Algernon Pharmaceuticals Inc subsidiary completes DMT escalating dose study of DMT to treat stroke and traumatic brain injury

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Neuro) has successfully completed dosing of the third...

Related Keywords

Netherlands ,Christopherj Moreau , ,Centre For Human Drug Research In Leiden ,Algernon Pharmaceuticals Inc ,Algernon Pharmaceuticals ,Algernon Neuroscience ,Human Drug Research ,